ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,41%
Bitcoin
62.820,36
6,26%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) News

EVGN Evogene Ltd

0,6951
-0,0104 (-1,47%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:53:02
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Evogene Ltd EVGN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,0104 -1,47% 0,6951 22:53:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,70 0,6706 0,7315 0,71 0,7055
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202413:00PRNUSBiomica to Present at the American Society of Clinical..
11.4.202413:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
02.4.202413:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
28.3.202414:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
20.3.202414:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
19.3.202414:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
13.3.202414:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
07.3.202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07.3.202413:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
06.3.202413:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
05.3.202413:00PRNUSCasterra Announces New Agreements with Seed Producers in..
01.3.202413:03EDGAR2Form F-3 - Registration statement by foreign private issuers
28.2.202413:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
26.2.202413:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
22.2.202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.2.202413:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
21.2.202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.2.202413:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
20.2.202413:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
15.2.202402:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202413:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
23.1.202413:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
17.1.202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.1.202413:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
09.1.202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.12.202313:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
19.12.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.12.202313:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
05.12.202313:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
28.11.202313:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
15.11.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.11.202313:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
08.11.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.11.202312:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
31.10.202312:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
18.10.202313:00PRNUSEvogene Provides Operational Update Amidst Current Security..
27.9.202313:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
21.9.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.9.202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.9.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.8.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.8.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.8.202313:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
15.8.202313:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
08.8.202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.8.202313:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
25.7.202313:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
19.7.202313:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
18.7.202320:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17.7.202314:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

NASDAQ
EVGN
Evogene
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten